Unrelated cord blood compared with haploidentical grafts in patients with hematological malignancies

Peripheral Blood Hematopoietic Stem Cells for Transplantation of Hematological Diseases from Related, Haploidentical Donors after Reduced-Intensity Conditioning

(2014) Kavita Raj et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Unmanipulated Haploidentical Transplants Compared with Other Alternative Donors and Matched Sibling Grafts

(2014) Anna Maria Raiola et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Bone Marrow Compared with Peripheral Blood Stem Cells for Haploidentical Transplantation with a Nonmyeloablative Conditioning Regimen and Post-transplantation Cyclophosphamide

(2014) Luca Castagna et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Multi-Institutional Study of Post-Transplantation Cyclophosphamide As Single-Agent Graft-Versus-Host Disease Prophylaxis After Allogeneic Bone Marrow Transplantation Using Myeloablative Busulfan and Fludarabine Conditioning

(2014) Christopher G. Kanakry et al.   JOURNAL OF CLINICAL ONCOLOGY

Haploidentical Transplantation Using T Cell Replete Peripheral Blood Stem Cells and Myeloablative Conditioning in Patients with High-Risk Hematologic Malignancies Who Lack Conventional Donors is Well Tolerated and Produces Excellent Relapse-Free Survival: Results of a Prospective Phase II Trial

(2012) Scott R. Solomon et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

A disease risk index for patients undergoing allogeneic stem cell transplantation

(2012) P. Armand et al.   BLOOD

Haploidentical stem cell transplantation for children with high-risk leukemia

(2012) Julia Palma et al.   PEDIATRIC BLOOD & CANCER

Post-Transplantation Cyclophosphamide for Tolerance Induction in HLA-Haploidentical Bone Marrow Transplantation

(2012) Leo Luznik et al.   SEMINARS IN ONCOLOGY

Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts

(2011) C. G. Brunstein et al.   BLOOD

HLA-C Antigen Mismatch Is Associated with Worse Outcome in Unrelated Donor Peripheral Blood Stem Cell Transplantation

(2010) Ann Woolfrey et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease

(2010) L. Luznik et al.   BLOOD

High-dose cyclophosphamide for graft-versus-host disease prevention

(2010) Leo Luznik et al.   CURRENT OPINION IN HEMATOLOGY

High-dose, post-transplantation cyclophosphamide to promote graft-host tolerance after allogeneic hematopoietic stem cell transplantation

(2010) Leo Luznik et al.   IMMUNOLOGIC RESEARCH

Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis

(2010) Mary Eapen et al.   LANCET ONCOLOGY

HLA-Haploidentical Stem Cell Transplantation for Hematologic Malignancies

(2009) Ephraim J. Fuchs et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Improving outcomes of cord blood transplantation: HLA matching, cell dose and other graft- and transplantation-related factors

(2009) Vanderson Rocha et al.   BRITISH JOURNAL OF HAEMATOLOGY

HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide

(2008) Leo Luznik et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Haploidentical haematopoietic stem cell transplantation for acute leukaemia in adults: experience in Europe and the United States

(2008) F Aversa   BONE MARROW TRANSPLANTATION